Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Elekta B Shs ADR (EKTAY)

Elekta B Shs ADR (EKTAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Elekta B Shs ADR Kungstensgatan 18 Box 7593 Stockholm V7 SE-103 93 SWE

www.elekta.com P: 46-8-587-254-00

Description:

Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden.

Key Statistics

Overview:

Market Capitalization, $K 2,765,525
Enterprise Value, $K 2,999,225
Shares Outstanding, K 383,568
Annual Sales, $ 1,614 M
Annual Net Income, $ 90,250 K
Last Quarter Sales, $ 426,510 K
Last Quarter Net Income, $ 28,670 K
EBIT, $ 114,120 K
EBITDA, $ 238,580 K
60-Month Beta 1.16
% of Insider Shareholders 41.28%
% of Institutional Shareholders 0.00%
Float, K 225,231
% Float 58.72%
Short Volume Ratio 0.17

Growth:

1-Year Return -15.61%
3-Year Return -48.24%
5-Year Return -37.09%
5-Year Revenue Growth 18.12%
5-Year Earnings Growth -14.29%
5-Year Dividend Growth 87.50%

Per-Share Information:

Most Recent Earnings 0.08 on 02/29/24
Latest Earnings Date 05/23/24
Earnings Per Share ttm 0.38
EPS Growth vs. Prev Qtr -11.11%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Rate, $ 0.15
Annual Dividend Yield 2.14%
Most Recent Dividend 0.079 on 02/26/24
Next Ex-Dividends Date 02/26/24
Dividend Payable Date 03/18/24
Dividend Payout Ratio 40.80%

EKTAY Ratios

Ratio
Price/Earnings ttm 18.86
Price/Earnings forward 16.52
Price/Earnings to Growth N/A
Return-on-Equity % 15.16%
Return-on-Assets % 5.01%
Profit Margin % 5.59%
Debt/Equity 0.57
Price/Sales 1.70
Price/Cash Flow 12.22
Price/Book 2.73
Book Value/Share 2.51
Interest Coverage 4.86

EKTAY Dividends

Date Value
02/26/24 $0.0790
08/25/23 $0.0750
02/24/23 $0.0780
08/26/22 $0.0760
02/25/22 $0.0770
08/26/21 $0.0880
04/19/21 $0.0730
08/27/20 $0.0700
02/21/20 $0.0630
08/23/19 $0.0620
03/01/19 $0.0500
08/30/18 $0.0520
02/22/18 $0.0400
08/23/17 $0.0420
03/02/17 $0.0190
08/31/16 $0.0200
09/01/15 $0.0410
09/04/13 $0.2250
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar